What You Should Know:
- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments.
- Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Biden-Harris Admin Awards $1.5B to Address Overdose Epidemic
What You Should Know:
- The U.S Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded nearly $1.5 billion to support states, tribal lands, and territories’ efforts to address the opioid crisis and support individuals in recovery.
- The grants are part of SAMHSA’s State Opioid Response and Tribal Opioid Response grant programs. The grant programs provide funding to states and territories to increase access to
Read More
Caris Life Sciences Integrates with Flatiron Health for Molecular Testing
What You Should Know:
- Caris Life Sciences, the leading molecular science and technology company, announced their partnership with Flatiron Health to fully integrate Caris’ molecular testing portfolio with Flatiron’s OncoEMR®, a cloud-based electronic medical record (EMR) tool.
- This partnership streamlines clinical workflows for physicians, delivering critical results directly at the point of care to help them make better treatment decisions for their patients.
Molecular
Read More
Naveris Raises $51M for Early Detection of Viral-Driven Cancers
What You Should Know:
- Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M.
- The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.
Using DNA Fragmentomics Technology to Detect
Read More
Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies
What You Should Know:
- Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function.
- The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and
Read More
Epic Launches Life Sciences Program with Clinical Trial Matchmaking
What You Should Know:
- Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare.
- The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies.
Unifying Clinical Research with Care Delivery
Providers across the world use Epic to
Read More
Size Matters When it Comes to Choosing The Right Stent
It doesn’t take long for kids to figure out that people come in all different shapes and sizes and that what differentiates us from one another is what makes us unique. And while we are told from a young age that we are all the same inside—that we all see, smell, taste, touch and hear the same as one another—there are nuances to this that become apparent as we age.Our vasculature is a good case in point. While our arteries all carry blood to and from the heart, they are not all the same size.
Read More
Intelerad Acquires Life Image to Expand Global Open Image Exchange Network
What You Should Know:
- Today, Intelerad, a global provider of enterprise medical imaging solutions, announced its acquisition of Life Image, one of the largest image exchange networks of curated clinical and imaging data.
- The acquisition, which closely follows Intelerad’s recent deal with PenRad Technologies, Inc. and acquisition of cloud imaging leader Ambra Health last year, creates the largest medical image exchange network in the world.
Acquisition Establishes Interlad as
Read More
Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
What You Should Know:
- Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
- The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
